date/time interval
- October 1, 2022 - April 30, 2025
A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings
Grant
Overview
awarded by
administered by
sponsor award ID
- 3 UG1 DA050077-04S1
Affiliation
contributor
- Jalali, Ali Co-Investigator 2022 - 2023
- Murphy, Sean M. Principal Investigator (Subaward) 2022 - 2023